The DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.
Tryptophan Metabolism in Depression: A Narrative Review with a Focus on Serotonin and Kynurenine Pathways
Open accessAbstract
Depression is a common and serious disorder, characterized by symptoms like anhedonia, lack of energy, sad mood, low appetite, and sleep disturbances. This disease is very complex and not totally elucidated, in which diverse molecular and biological mechanisms are involved, such as neuroinflammation. There is a high need for the development of new therapies and gaining new insights into this disease is urgent. One important player in depression is the amino acid tryptophan. This amino acid can be metabolized in two important pathways in the context of depression: the serotonin and kynurenine pathways. These metabolic pathways of tryptophan are crucial in several processes that are linked with depression. Indeed, the maintenance of the balance of serotonin and kynurenine pathways is critical for the human physiological homeostasis. Thus, this narrative review aims to explore tryptophan metabolism (particularly in the serotonin and kynurenine pathways) in depression, starting with a global overview about these topics and ending with the focus on these pathways in neuroinflammation, stress, microbiota, and brain-derived neurotrophic factor regulation in this disease. Taken together, this information aims to clarify the metabolism of tryptophan in depression, particularly the serotonin and kynurenine pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Miller, A. H., & Raison, C. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.5 · Cited by 3,942 · cited 1×
“There is a large amount of evidence showing that, in patients with depression, proinflammatory cytokines originated by the microglia (TNF-α for example) reduce the presence of 5-HT [60].”
BackgroundCytokines, Inflammation, and Pain
Zhang, J.-M., & An, J. (2007) · International Anesthesiology Clinics · doi:10.1097/aia.0b013e318034194e · Cited by 2,945
Sudo, N., Chida, Y., Aiba, Y., Sonoda, J., Oyama, N., Yu, X., Kubo, C., & Koga, Y. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.063388 · Cited by 2,735
Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites
Wikoff, W. R., Anfora, A. T., Liu, J., Schultz, P. G., Lesley, S. A., Peters, E. C., & Siuzdak, G. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812874106 · Cited by 2,677
Otte, C., Gold, S. M., Penninx, B. W., Pariante, C. M., Etkin, A., Fava, M., Mohr, D. C., & Schatzberg, A. F. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.65 · Cited by 2,269
Microbial tryptophan catabolites in health and disease
Roager, H. M., & Licht, T. R. (2018) · Nature Communications · doi:10.1038/s41467-018-05470-4 · Cited by 2,236
The expanded biology of serotonin
Berger, M., Gray, J. A., & Roth, B. L. (2009) · Annual Review of Medicine · doi:10.1146/annurev.med.60.042307.110802 · Cited by 2,100 · cited 2×
“Serotonergic networks are crucial in behavioral aspects (such as mood, sexuality, memory, appetite, stress response, and anger), as well as other central nervous system effects (like motor control, regulation of circadian rhythm, and body temperature) and effects outside of the central nervous system, such as gastroin…”
BackgroundSynaptic plasticity and depression: new insights from stress and rapid-acting antidepressants
Duman, R. S., Aghajanian, G. K., Sanacora, G., & Krystal, J. H. (2016) · Nature Medicine · doi:10.1038/nm.4050 · Cited by 1,750
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
Platten, M., Nollen, E. A. A., Röhrig, U. F., Fallarino, F., & Opitz, C. A. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0016-5 · Cited by 1,586
Kynurenines: Tryptophan’s metabolites in exercise, inflammation, and mental health
Cervenka, I., Agudelo, L. Z., & Ruas, J. L. (2017) · Science · doi:10.1126/science.aaf9794 · Cited by 1,382
O'Connor, J. C., Lawson, M. A., André, C., Moreau, M., Lestage, J., Castanon, N., Kelley, K. W., & Dantzer, R. (2009) · Molecular Psychiatry · doi:10.1038/sj.mp.4002148 · Cited by 1,278 · cited 1×
“Indeed, LPS exposure increased brains’ IDO mRNA expression in rodents, resulting in overactivation of the Kyn pathway [79].”
BackgroundParoxetine for the prevention of depression induced by high-dose interferon alfa.
Musselman, D. L., Lawson, D. H., Gumnick, J. F., Manatunga, A. K., Penna, S., Goodkin, R. S., Greiner, K., Nemeroff, C. B., & Miller, A. H. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103293441303 · Cited by 1,120 · cited 1×
“Paroxetine, an SSRI, has also been demonstrated to be an effective treatment for minimizing depression induced by IFNα, in patients with melanoma and hepatitis C [69,70].”
BackgroundNeuroinflammation and depression: A review
Troubat, R., Barone, P., Leman, S., Desmidt, T., Cressant, A., Atanasova, B., Brizard, B., El Hage, W., Surget, A., Belzung, C., et al. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.14720 · Cited by 1,107
Russell, G., & Lightman, S. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0228-0 · Cited by 1,032
Desbonnet, L., Garrett, L., Clarke, G., Bienenstock, J., & Dinan, T. G. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.03.009 · Cited by 952
Interaction between BDNF and Serotonin: Role in Mood Disorders
Martinowich, K., & Lu, B. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301571 · Cited by 793
The kynurenine pathway: a finger in every pie
Savitz, J. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0414-4 · Cited by 756
Agudelo, L. Z., Femenía, T., Orhan, F., Porsmyr-Palmertz, M., Goiny, M., Martinez-Redondo, V., Correia, J. C., Izadi, M., Bhat, M., Schuppe-Koistinen, I., et al. (2014) · Cell · doi:10.1016/j.cell.2014.07.051 · Cited by 739
Steiner, J., Walter, M., Gos, T., Guillemin, G. J., Bernstein, H.-G., Sarnyai, Z., Mawrin, C., Brisch, R., Bielau, H., zu Schwabedissen, L., et al. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-94 · Cited by 568
Glucocorticoids, cytokines and brain abnormalities in depression
Zunszain, P. A., Anacker, C., Cattaneo, A., Carvalho, L. A., & Pariante, C. M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.04.011 · Cited by 554
Zhu, C.-B., Blakely, R. D., & Hewlett, W. A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301029 · Cited by 549
Guillemin, G. J., Smythe, G., Takikawa, O., & Brew, B. J. (2005) · Glia · doi:10.1002/glia.20090 · Cited by 497
Gareau, M. G., Jury, J., MacQueen, G., Sherman, P. M., & Perdue, M. H. (2007) · Gut · doi:10.1136/gut.2006.117176 · Cited by 472 · cited 1×
“normalized the elevated corticosterone levels present in rats after maternal separation [88].”
BackgroundEadie, B. D., Redila, V. A., & Christie, B. R. (2005) · Journal of Comparative Neurology · doi:10.1002/cne.20493 · Cited by 466
Tryptophan Metabolic Pathways and Brain Serotonergic Activity: A Comparative Review
Höglund, E., Øverli, Ø., & Winberg, S. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00158 · Cited by 438
The Impact of Studying Brain Plasticity
Mateos-Aparicio, P., & Rodríguez-Moreno, A. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00066 · Cited by 381
Jesulola, E., Micalos, P., & Baguley, I. J. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.12.025 · Cited by 379
What has serotonin to do with depression?
Cowen, P. J., & Browning, M. (2015) · World Psychiatry · doi:10.1002/wps.20229 · Cited by 374
Microbiota alteration is associated with the development of stress-induced despair behavior
Marin, I. A., Goertz, J. E., Ren, T., Rich, S. S., Onengut-Gumuscu, S., Farber, E., Wu, M., Overall, C. C., Kipnis, J., & Gaultier, A. (2017) · Scientific Reports · doi:10.1038/srep43859 · Cited by 369
Deng, Y., Zhou, M., Wang, J., Yao, J., Yu, J., Liu, W., Wu, L., Wang, J., & Gao, R. (2021) · Gut Microbes · doi:10.1080/19490976.2020.1869501 · Cited by 362
Beyond a neurotransmitter: The role of serotonin in inflammation and immunity
Wu, H., Denna, T. H., Storkersen, J. N., & Gerriets, V. A. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2018.06.015 · Cited by 338
Ali, T., Rahman, S. U., Hao, Q., Li, W., Liu, Z., Ali Shah, F., Murtaza, I., Zhang, Z., Yang, X., Liu, G., et al. (2020) · Journal of Pineal Research · doi:10.1111/jpi.12667 · Cited by 325
Zhu, C.-B., Lindler, K. M., Owens, A. W., Daws, L. C., Blakely, R. D., & Hewlett, W. A. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.116 · Cited by 317
Cytokine Research in Depression: Principles, Challenges, and Open Questions
Himmerich, H., Patsalos, O., Lichtblau, N., Ibrahim, M. A. A., & Dalton, B. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00030 · Cited by 313
Bay-Richter, C., Linderholm, K. R., Lim, C. K., Samuelsson, M., Träskman-Bendz, L., Guillemin, G. J., Erhardt, S., & Brundin, L. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.07.012 · Cited by 304
Tryptophan in health and disease
(2020) · Advances in Clinical Chemistry · doi:10.1016/bs.acc.2019.08.005 · Cited by 294
Placidi, G. P. A., Oquendo, M. A., Malone, K. M., Huang, Y.-Y., Ellis, S. P., & Mann, J. J. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01170-2 · Cited by 288
Tryptophan Metabolism as a Pharmacological Target
Modoux, M., Rolhion, N., Mani, S., & Sokol, H. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.11.006 · Cited by 284
Miura, H., Ozaki, N., Sawada, M., Isobe, K., Ohta, T., & Nagatsu, T. (2008) · Stress · doi:10.1080/10253890701754068 · Cited by 282
Hardeland, R. (2012) · Europe PMC (PubMed Central) · Cited by 279
Oxenkrug, G. F. (2010) · PubMed · Cited by 261
Miller, A. H. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.08.006 · Cited by 261
Maffei, M. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010181 · Cited by 236
Depression and anxiety during COVID-19
Daly, M., & Robinson, E. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00187-8 · Cited by 236
Probiotic modulation of the microbiota-gut-brain axis and behaviour in zebrafish
Borrelli, L., Aceto, S., Agnisola, C., De Paolo, S., Dipineto, L., Stilling, R. M., Dinan, T. G., Cryan, J. F., Menna, L. F., & Fioretti, A. (2016) · Scientific Reports · doi:10.1038/srep30046 · Cited by 225 · cited 1×
“Additionally, a significant increase in Firmicutes was also observed [97].”
BackgroundChen, Y., Jiang, T., Chen, P., Ouyang, J., Xu, G., Zeng, Z., & Sun, Y. (2011) · Psychiatry Research · doi:10.1016/j.psychres.2010.10.029 · Cited by 209
Bach-Mizrachi, H., Underwood, M. D., Kassir, S. A., Bakalian, M. J., Sibille, E., Tamir, H., Mann, J. J., & Arango, V. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300897 · Cited by 190
Kiraly, D. D., Horn, S. R., Van Dam, N. T., Costi, S., Schwartz, J., Kim-Schulze, S., Patel, M., Hodes, G. E., Russo, S. J., Merad, M., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.31 · Cited by 186
The serotonin-BDNF duo: developmental implications for the vulnerability to psychopathology
Homberg, J. R., Molteni, R., Calabrese, F., & Riva, M. A. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.03.012 · Cited by 177
Hunt, C., Cordeiro, T. M. E., Suchting, R., de Dios, C., Cuellar, V. A., Soares, J. C., Dantzer, R., Teixeira, A. L., & Selvaraj, S. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.08.010 · Cited by 165
O'Farrell, K., & Harkin, A. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.12.004 · Cited by 164
Achtyes, E. D., Keaton, S. A., Smart, L., Burmeister, A. R., Heilman, P. L., Krzyżanowski, S., Nagalla, M., Guillemin, G. J., Galvis, M. L. E., Lim, C. K., et al. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.10.017 · Cited by 163
The Effects of Dietary Tryptophan on Affective Disorders
Lindseth, G., Helland, B., & Caspers, J. (2015) · Archives of Psychiatric Nursing · doi:10.1016/j.apnu.2014.11.008 · Cited by 162
Lawson, M. A., Parrott, J. M., McCusker, R. H., Dantzer, R., Kelley, K. W., & O’Connor, J. C. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-87 · Cited by 161
Gutted! Unraveling the Role of the Microbiome in Major Depressive Disorder
Bastiaanssen, T. F. S., Cussotto, S., Claesson, M. J., Clarke, G., Dinan, T. G., & Cryan, J. F. (2020) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000243 · Cited by 159
Chen, M.-H., Li, C.-T., Lin, W.-C., Hong, C.-J., Tu, P.-C., Bai, Y.-M., Cheng, C.-M., & Su, T.-P. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.08.078 · Cited by 159
RAISON, C. L., WOOLWINE, B. J., DEMETRASHVILI, M. F., BORISOV, A. S., WEINREIB, R., STAAB, J. P., ZAJECKA, J. M., BRUNO, C. J., HENDERSON, M. A., REINUS, J. F., et al. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03316.x · Cited by 142 · cited 1×
“Paroxetine, an SSRI, has also been demonstrated to be an effective treatment for minimizing depression induced by IFNα, in patients with melanoma and hepatitis C [69,70].”
BackgroundTetrahydrobioterin (BH4) pathway: from metabolism to neuropsychiatry
Fanet, H., Capuron, L., Castanon, N., Calon, F., & Vancassel, S. (2021) · Current Neuropharmacology · doi:10.2174/1570159x18666200729103529 · Cited by 134
The role of monoamine oxidase enzymes in the pathophysiology of neurological disorders
Jones, D. N., & Raghanti, M. A. (2021) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2021.101957 · Cited by 134
The kynurenine pathway in major depression: What we know and where to next
Brown, S. J., Huang, X., & Newell, K. A. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.05.018 · Cited by 130
Aerobic exercise upregulates the BDNF-Serotonin systems and improves the cognitive function in rats
Pietrelli, A., Matković, L., Vacotto, M., López‐Costa, J. J., Basso, N., & Brusco, A. (2018) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2018.05.007 · Cited by 126
Wang, D., Wu, J., Zhu, P., Xie, H., Lu, L., Bai, W., Pan, W., Shi, R., Ye, J., Xia, B., et al. (2022) · Food Research International · doi:10.1016/j.foodres.2022.111289 · Cited by 126
Ketamine’s effect on inflammation and kynurenine pathway in depression: A systematic review
Kopra, E. I., Mondelli, V., Pariante, C. M., & Nikkheslat, N. (2021) · Journal of Psychopharmacology · doi:10.1177/02698811211026426 · Cited by 114
Guillemin, G. J., Smith, D. G., Kerr, S. J., Smythe, G. A., Kapoor, V., Armati, P. J., & Brew, B. J. (2000) · Redox Report · doi:10.1179/135100000101535375 · Cited by 108
Moriguchi, S., Wilson, A. A., Miler, L., Rusjan, P., Vasdev, N., Kish, S. J., Rajkowska, G., Wang, J., Bagby, M. R., Mizrahi, R., et al. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.0044 · Cited by 106
Messaoud, A., Mensi, R., Douki, W., Neffati, F., Najjar, M. F., Gobbi, G., Valtorta, F., Gaha, L., & Comai, S. (2018) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2018.1468031 · Cited by 105
Gibney, S. M., Fagan, E. M., Waldron, A., O’Byrne, J., Connor, T. J., & Harkin, A. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713001673 · Cited by 104
Kaltenboeck, A., & Harmer, C. J. (2018) · Brain and Neuroscience Advances · doi:10.1177/2398212818799269 · Cited by 104
Kadriu, B., Farmer, C., Yuan, P., Park, L. T., Deng, Z., Moaddel, R., Henter, I. D., Shovestul, B. J., Ballard, E. D., Kraus, C., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0589-8 · Cited by 99
STRESS AND TRAUMA: Psychotherapy and Pharmacotherapy for Depersonalization/Derealization Disorder.
Gentile, J. P., Snyder, M., & Gillig, P. M. (2014) · Europe PMC (PubMed Central) · Cited by 97
Hsu, C., & Tain, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228705 · Cited by 95
Melatonin and Depression: A Translational Perspective From Animal Models to Clinical Studies
Tonon, A. C., Pilz, L. K., Markus, R. P., Hidalgo, M. P. L., & Elisabetsky, E. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.638981 · Cited by 89
Rewiring of the Serotonin System in Major Depression
Vahid-Ansari, F., & Albert, P. R. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.802581 · Cited by 87
Does escitalopram reduce neurotoxicity in major depression?
Halaris, A., Myint, A.-M., Savant, V., Meresh, E., Lim, E., Guillemin, G., Hoppensteadt, D., Fareed, J., & Sinacore, J. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.04.026 · Cited by 86
Melatonin and neurotrophins NT-3, BDNF, NGF in patients with varying levels of depression severity
Ogłodek, E. A., Just, M. J., Szromek, A. R., & Araszkiewicz, A. S. (2016) · Pharmacological Reports · doi:10.1016/j.pharep.2016.04.003 · Cited by 86
Zhou, Y., Zheng, W., Liu, W., Wang, C., Zhan, Y., Li, H., Chen, L., Li, M., & Ning, Y. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.09.007 · Cited by 86
Gao, K., Farzi, A., Ke, X., Yu, Y., Chen, C., Chen, S., Yu, T., Wang, H., & Li, Y. (2021) · Food & Function · doi:10.1039/d1fo03723d · Cited by 86
Ryan, N. D. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110007001 · Cited by 82
IDO and TDO as a potential therapeutic target in different types of depression
Qin, Y., Wang, N., Zhang, X., Han, X., Zhai, X., & Lu, Y. (2018) · Metabolic Brain Disease · doi:10.1007/s11011-018-0290-7 · Cited by 81
Neurobiology of Stress-Induced Reproductive Dysfunction in Female Macaques
Bethea, C. L., Centeno, M. L., & Cameron, J. L. (2008) · Molecular Neurobiology · doi:10.1007/s12035-008-8042-z · Cited by 79
The Challenges of Improving Treatments for Depression
Cuijpers, P. (2018) · JAMA · doi:10.1001/jama.2018.17824 · Cited by 78 · cited 3×
“One of the major problems associated with depression is the high rate of recurrence, therapy failure, and lack of diagnosis/treatment, especially in low- and middle-income countries [1,2,9].”
BackgroundRamírez, L. A., Padilla, E. A. P., García‐Oscos, F., Salgado, H., Atzori, M., & Pineda, J. C. (2018) · Biomédica · doi:10.7705/biomedica.v38i3.3688 · Cited by 77
Antidepressant potentiation of 5-hydroxytryptophan by L-deprenil in affective illness
MENDLEWICZ, J., & Youdim, M. B. H. (1980) · Journal of Affective Disorders · doi:10.1016/0165-0327(80)90013-0 · Cited by 70
Severe deficits in 5‐HT2A‐mediated neurotransmission in BDNF conditional mutant mice
Rios, M., Lambe, E. K., Liu, R., Teillon, S., Liu, J., Akbarian, S., Roffler-Tarlov, S. K., Jaenisch, R., & Aghajanian, G. K. (2006) · Journal of Neurobiology · doi:10.1002/neu.20233 · Cited by 68
Park, S.-A., Son, S. Y., Lee, A.-Y., Park, H.-G., Lee, W.-L., & Lee, C. H. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17020541 · Cited by 68
COVID-19, Oxidative Stress, and Neuroinflammation in the Depression Route
Mingoti, M. E. D., Bertollo, A. G., Simões, J. L. B., Francisco, G. R., Bagatini, M. D., & Ignácio, Z. M. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-02004-y · Cited by 64
Dugan, A. M., Parrott, J. M., Redus, L., Hensler, J. G., & O’Connor, J. C. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv089 · Cited by 63
Association between single nucleotide polymorphisms of TPH1 and TPH2 genes, and depressive disorders
Wigner, P., Czarny, P. L., Synowiec, E., Bijak, M., Białek, K. I., Talarowska, M. E., Gałecki, P., Szemraj, J., & Śliwiński, T. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13459 · Cited by 63
Neumeister, A., Yuan, P., Young, T. A., Bonne, O. B., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.4.805 · Cited by 58
Zhuo, C., Jiang, R., Ye, M., Jiang, D., Jin, S., Li, G., Li, Q., Li, Z., & Ma, H. (2016) · Neural Regeneration Research · doi:10.4103/1673-5374.191222 · Cited by 58
The Role of Monoamine Oxidase Inhibitors in Depression Treatment Guidelines
Thase, M. E. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11096su1c.02 · Cited by 56
Stress inhibits tryptophan hydroxylase expression in a rat model of depression
Chen, Y., Xu, H., Zhu, M., Liu, K., Lin, B., Luo, R., Chen, C., & Li, M. (2017) · Oncotarget · doi:10.18632/oncotarget.18780 · Cited by 55
Hensler, J. G., Advani, T., & Monteggia, L. M. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.10.015 · Cited by 54
Musumeci, G., Castrogiovanni, P., Castorina, S., Imbesi, R., Szychlinska, M. A., Scuderi, S., Loreto, C., & Giunta, S. (2015) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2015.09.010 · Cited by 54
Selective Serotonin Reuptake Inhibitors
Ogata, N., Dantas, L. M. D. S., & Crowell‐Davis, S. L. (2019) · Wiley eBooks · doi:10.1002/9781119226253.ch8 · Cited by 50
Correia, A. S., Cardoso, A., & Vale, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168525 · Cited by 49
Self-citationAntidepressants in Alzheimer’s Disease: A Focus on the Role of Mirtazapine
Correia, A. S., & Vale, N. (2021) · Pharmaceuticals · doi:10.3390/ph14090930 · Cited by 45
Self-citationA new perspective on depression and neuroinflammation: Non-coding RNA
Zhou, S., Chen, R., She, Y., Liu, X., Zhao, H., Li, C., & Jia, Y. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.02.007 · Cited by 45
Dewulf, J. P., Martin, M., Marie, S., Oguz, F., Belkhir, L., Greef, J. D., Yombi, J. C., Wittebole, X., Laterre, P., Jadoul, M. Y., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-14292-w · Cited by 43
Delgado, I., Cussotto, S., Anesi, A., Dexpert, S., Aubert, A., Aouizerate, B., Beau, C., Forestier, D., Ledaguenel, P., Magne, E., et al. (2022) · International Journal of Obesity · doi:10.1038/s41366-021-01049-0 · Cited by 42
Zhang, F., Zhu, X., Yu, P., Sheng, T., Wang, Y., & Ye, Y. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2022.105343 · Cited by 39
Etiological classification of depression based on the enzymes of tryptophan metabolism
Fukuda, K. (2014) · BMC Psychiatry · doi:10.1186/s12888-014-0372-y · Cited by 37
Dawood, S., Bano, S., & Badawy, A. A. ‐. (2022) · Bioscience Reports · doi:10.1042/bsr20220426 · Cited by 33
5-Hydroxytryptophan (5-HTP) and a MAOI (Nialamide) in the Treatment of Depressions
Aliño, J. J. L.-I., Jl, A. G., & Iglesias, M. L. M. (2017) · International Pharmacopsychiatry · doi:10.1159/000468207 · Cited by 30
Evsiukova, V. S., Базовкина, Д. В., Bazhenova, E., Kulikova, E. A., & Kulikov, A. V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312851 · Cited by 30
Zhu, X., Sun‐Waterhouse, D., Tao, Q., Li, W., Shu, D., & Cui, C. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.103859 · Cited by 28
Gao, L., Gao, T., Zeng, T., Huang, P., Wong, N.-K., Dong, Z., Li, Y., Deng, G., Wu, Z., & Lv, Z. (2021) · Aging · doi:10.18632/aging.202511 · Cited by 28
Saccharomyces boulardii attenuates lipopolysaccharide-induced anxiety-like behaviors in rats
Babaei, F., Mirzababaei, M., Mohammadi, G., Dargahi, L., & Nassiri‐Asl, M. (2022) · Neuroscience Letters · doi:10.1016/j.neulet.2022.136600 · Cited by 26
Myint, K., Jacobs, K. R., Myint, A.-M., Lam, S. K., Henden, L., Hoe, S.-Z., & Guillemin, G. J. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252668 · Cited by 23
Li, H., Wang, P., Zhou, Y., Zhao, F., Gao, X. M., Wu, C., Wu, T., Jiang, L., & Zhang, D. (2022) · Genes Brain & Behavior · doi:10.1111/gbb.12806 · Cited by 23
Kynurenine pathway is altered in BDNF Val66Met knock-in mice: Effect of physical exercise
Ieraci, A., Beggiato, S., Ferraro, L., Barbieri, S. S., & Popoli, M. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.07.031 · Cited by 22
Wei, Z., Wang, Y., Shi, Z., Zhou, N., Ren, G., Hao, X., Zou, L., & Yao, Y. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c05220 · Cited by 22
Youssef, B., Ramadan, K. S., ElShebiney, S. A., & Ibrahim, E. A. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14164 · Cited by 20
Kocki, T., Urbańska, E. M., Kocki, J., Kloc, R., Kocka, K., Olajossy, M., & Owe‐Larsson, B. (2018) · Pharmacological Reports · doi:10.1016/j.pharep.2018.01.004 · Cited by 19
de Oliveira, C. M., de Smedt-Peyrusse, V., Morael, J., Vancassel, S., Capuron, L., Gaudout, D., Pourtau, L., & Castanon, N. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122155 · Cited by 18
Li, C., Ye, F., Xu, C.-X., Chang, Q., Liu, X., & Pan, R. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115349 · Cited by 15
Tsao, C. ‐., Lin, Y. ‐., Cheng, J., Chang, W. ‐., Chen, C. ‐., Wu, S. ‐., Fan, C. ‐., & Lo, H. ‐. (2006) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2005.01715.x · Cited by 14
Torre, D. L., Dalile, B., de Loor, H., Oudenhove, L. V., & Verbeke, K. (2021) · Stress · doi:10.1080/10253890.2021.1959546 · Cited by 14
Samant, N. P., & Gupta, G. L. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-00971-0 · Cited by 8
Cited by
Xie, S., Wang, C., Song, J., Zhang, Y., Wang, H., Chen, X., & Suo, H. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c03870 · Cited by 27
Milic, J., Jovic, S., & Sapic, R. (2025) · Genes · doi:10.3390/genes16050487 · Cited by 19
Chehadi, A. C., Pereira de Lima, E., Detregiachi, C. R. P., Santos de Argollo Haber, R., Catharin, V. M. C. S., Fornari Laurindo, L., Engracia Valenti, V., Machado Galhardi, C., Tanaka, M., & Maria Barbalho, S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27010465 · Cited by 8
Metadata
- Authors
- Correia, A. S., & Vale, N.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-07-31
- Volume
- 23
- Issue
- 15
- Pages
- 8493
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W4289174576
- Cited by
- 350
- References
- 119
- FWCI
- 5.88
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.